DEVON, Pa. (AP) _ Zynerba Pharmaceuticals Inc. (ZYNE) on Thursday reported a loss of $7.8 million in its third quarter.
On a per-share basis, the Devon, Pennsylvania-based company said it had a loss of 47 cents.
Zynerba shares have declined 52 percent since the beginning of the year. The stock has dropped 44 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZYNE at https://www.zacks.com/ap/ZYNE